The mTOR/AMPK signaling axis in placental dysfunction and preeclampsia: mechanisms and therapeutic targeting with metformin.

Preeclampsia continues to be one of the main causes of maternal and fetal complications in the absence of any effective treatment apart from placental expulsion. The present review presents a systematic evaluation of the involvement …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Unraveling cellular longevity pathways in poultry under heat stress: functional and computational characterization of the adaptogenic formulation Phytocee™.

UNLABELLED: Heat stress significantly disrupts physiological and molecular balance in poultry, leading to oxidative damage, inflammatory responses, and metabolic dysregulation. Among emerging solutions, phytogenic adaptogens have shown promise as natural agents that enhance resilience against …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Bench to bedside: is rapamycin headed for the docTOR?

Almost a century ago, calorie restriction (CR) was identified as a robust intervention for extending lifespan and healthspan, a discovery that captured the imagination of both scientists and the public. If the powerful mechanisms engaged …

44 Early
Design 5
Sample 7
Peer Review 16
Replication 6
Transparency 10

The nuts-and-bolts of ribosomal protein s6 kinase 1 regulation: A shared responsibility for mTOR complexes 1 and 2.

Ribosomal protein S6 kinase 1 (S6K1) is a master regulator of cell growth and metabolism and a primary effector of the mTOR signaling pathway. Given its central role in cancer and metabolic diseases, S6K1 is …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Synergistic dual targeting of mTOR and GLS1 overcomes glutamine-driven resistance in triple-negative breast cancer.

Resistance to therapeutic agents represents a critical barrier in the clinical management of triple-negative breast cancer (TNBC), necessitating novel therapeutic strategies. We discovered that mammalian target of rapamycin (mTOR) and glutaminase 1 (GLS1) mediated glutamine …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

CNDP2 drives renal tubular fibrosis in diabetic kidney disease via a sulfur-containing amino acids-mTOR signaling axis.

BACKGROUND: Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease, with proximal tubule fibrosis being a key pathological feature. Our previous study identified significant upregulation of cytosolic nonspecific dipeptidase 2 (CNDP2) in …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Omipalisib reduces hyperphosphorylated tau protein by modulating mTOR-autophagy pathway.

Tauopathies are neurodegenerative diseases characterized by the presence of hyperphosphorylated tau (p-tau) and neurofibrillary tangles. Autophagy is a critical self-degradation mechanism that preserves cellular homeostasis and function, including the clearance of misfolded proteins. Autophagy is …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

mTOR-NAA10-C7orf50 axis senses nutritional status to coordinate ribosome biogenesis and autophagy.

Cellular metabolism is precisely regulated in response to nutrient availability. As an extremely energy-consuming anabolic process, ribosome biogenesis should be tightly controlled in response to nutrient supply. However, how the nucleolus responds to different nutrient …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

Computer Model Suggests Combining Four Drugs May Slow Aging Better Than Using Them Alone

A computer model suggests that combining four existing drugs differently might slow aging better than current uses, but human testing is needed.

Researchers built a computer simulation of how aging works in the body and tested which combination of four existing drugs (semaglutide, SGLT2 inhibitors, metformin, and rapamycin) might slow aging most effectively. The model suggests that …

21 Weak
Design 5
Sample 2
Peer Review 3
Replication 4
Transparency 7

mTOR drives cerebrovascular dysfunction and blood-brain barrier breakdown in a model of Alzheimers disease with cerebral amyloid angiopathy

Cerebral amyloid angiopathy (CAA) is characterized by the deposition of amyloid {beta} fibrils (A{beta}) within walls of the cerebrovasculature and contributes to intracerebral hemorrhage, ischemic stroke, and cognitive dysfunction in patients with Alzheimers disease (AD) …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

A Protein That Shortens Life: Turning Off pitp-1 Extends Healthspan in Worms

Turning off one protein in worm brains extended lifespan and kept muscles stronger longer—a clue to how aging might be controlled.

Researchers found that a protein called pitp-1 acts as a brake on longevity by activating mTOR signaling—a key aging pathway. Disabling pitp-1 in neurons extended lifespan, improved muscle function, and boosted stress resistance in C. …

44 Early
Design 6
Sample 8
Peer Review 15
Replication 6
Transparency 9

The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by demyelination, neuroinflammation, and progressive neurodegeneration. The mechanistic target of rapamycin (mTOR) pathway plays a key role in regulating immune responses, cell metabolism, autophagy, and repair …

51 Promising
Design 18
Sample 7
Peer Review 10
Replication 6
Transparency 10

Caloric restriction rejuvenates aged adult stem cells: From mechanisms to interventions.

Adult stem cells are essential for maintaining tissue homeostasis and facilitating tissue repair. The ability of aged stem cells to generate functional progeny declines, which is closely associated with the onset and progression of age-related …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Delayed forebrain excitatory and inhibitory neurogenesis in STRADA-related megalencephaly via mTOR hyperactivity.

Biallelic pathogenic variants in STRADA (STE20-related adaptor alpha), an upstream regulator of the mechanistic target of rapamycin (mTOR) pathway, result in megalencephaly, drug-resistant epilepsy, and severe intellectual disability. This study explores how mTOR pathway hyperactivity …

46 Early
Design 5
Sample 7
Peer Review 18
Replication 6
Transparency 10

Rapamycin reduces age-related motor decline in mice, especially in females

Researchers gave aging mice rapamycin and found it prevented the normal decline in movement and motor control, with females benefiting more than males. The benefits appear linked to reduced oxidative stress and cellular stress in …

47 Early
Design 6
Sample 9
Peer Review 16
Replication 6
Transparency 10

Mendelian Randomization Revealed Potential of mTOR Inhibitors for Treatment of Osteoporosis: Evidence From GWAS and Transcriptome Data.

AIMS: Numerous preclinical studies suggested that targeted inhibition of mammalian target of rapamycin (mTOR) may be beneficial for the treatment of osteoporosis. However, the relevance of these findings to human populations remains unclear. We hypothesized …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Atractylenolide I ameliorates acute-on-chronic liver failure (ACLF) by promoting autophagy and preserving mitochondrial function through mTOR inhibition.

Acute-on-chronic liver failure (ACLF) is a severe liver syndrome marked by systemic inflammation and high mortality, often complicated by autophagy impairment and mitochondrial dysfunction. This study investigates atractylenolide I (AT-1), a compound from Atractylodes macrocephala, …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10

Non-Genetic Mechanisms of Fractional Resistance to Abemaciclib in Dedifferentiated Liposarcoma.

Dedifferentiated liposarcoma is a rare mesenchymal malignancy driven by amplification of chromosome 12q13-15, which includes the oncogenes CDK4 and MDM2. CDK4 amplification provides a rationale for targeted therapy with CDK4/6 inhibitors, and abemaciclib has shown …

34 Early
Design 5
Sample 7
Peer Review 4
Replication 6
Transparency 12

How Jellyfish Sense Stress and Trigger Regeneration: A Protein Map

Researchers mapped the proteins in immortal jellyfish (Turritopsis) that detect environmental stress and decide whether to stay dormant or regenerate. They identified a three-layer signaling architecture centered on mTORC1—a key aging pathway—that could offer clues …

37 Early
Design 5
Sample 5
Peer Review 12
Replication 5
Transparency 10

Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets.

INTRODUCTION/BACKGROUND: Therapy-Induced Senescence (TIS) is increasingly recognized as a clinically relevant outcome of anticancer therapy, particularly after sublethal genotoxic stress. In Non-Hodgkin Lymphomas (NHL), TIS may coexist with apoptosis and contribute to treatment heterogeneity by …

38 Early
Design 5
Sample 7
Peer Review 10
Replication 6
Transparency 10